![Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies | British Journal of Ophthalmology Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies | British Journal of Ophthalmology](https://bjo.bmj.com/content/bjophthalmol/103/1/125/DC1/embed/inline-supplementary-material-1.jpg?download=true)
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies | British Journal of Ophthalmology
![Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies | British Journal of Ophthalmology Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies | British Journal of Ophthalmology](https://bjo.bmj.com/content/bjophthalmol/103/1/125/F4.large.jpg)
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies | British Journal of Ophthalmology
![Abb. 1: Cyclosporin-Blutkonzentrationen über die Zeit nach Gabe als... | Download Scientific Diagram Abb. 1: Cyclosporin-Blutkonzentrationen über die Zeit nach Gabe als... | Download Scientific Diagram](https://www.researchgate.net/profile/Ernst-Scheuermann/publication/237211171/figure/fig1/AS:648963069841427@1531736261956/Abb-1-Cyclosporin-Blutkonzentrationen-ueber-die-Zeit-nach-Gabe-als-Mikroemulsion-nach.png)